Biblio

Jaidi Y, Guilloteau A, Nonnonhou V, Bertholon L-A, Badr S, Morrone I, Novella J-L, Mahmoudi R.  2019.  Threshold for a Reduction in Anticholinergic Burden to Decrease Behavioral and Psychological Symptoms of Dementia. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 20:159+.

Thiery-Antier N, Binquet C, Vinault S, Meziani F, Boisrame-Helms J, Quenot J-P, Grp EPISeptic Sho.  2016.  Is Thrombocytopenia an Early Prognostic Marker in Septic Shock? CRITICAL CARE MEDICINE. 44:764-772.

Gourbil M, Grandvuillemin A, Beyens M-N, Massy N, Gras V, D'Amico A, Miremont-Salame G, Petitpain N, Pharmacovi FNetwork Re.  2014.  Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals. DRUG SAFETY. 37:269–282.

Bouchain C., Valnet-Rabier M.B, Davani S., N. Bertrand M, Humbert S..  2018.  Thromboembolic events in women exposed to hormonal contraception: regional comparison with data from the national pharmacovigilance survey carried out in 2012 and evaluation of prescription practices after new national guidelines. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:29.

Orvain C, Balsat M, Tavernier E, Marolleau J-P, Pabst T, Chevallier P, De Gunzburg N, Cacheux V, Huguet F, Chantepie S et al..  2020.  Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. BLOOD. 136:328-338.

Murao K, Leys D, Jacquin A, Kitazono T, Bordet R, Bejot Y, Kimura K, Godefroy O, Wakisaka Y, Moulin S et al..  2014.  Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. NEUROLOGY. 82:2048-2054.

Murao K., Leys D., Jacquin A., Kitazono T., Bordet R., Bejot Y., Kimura K., Godefroy O., Moulin S., Ago T. et al..  2014.  Thrombolytic Therapy for Stroke in Patients with Pre-existing Cognitive Impairment.. CEREBROVASCULAR DISEASES. 37:98.

Lim MYeong, Deal A, Conard J, Dutrillaux F, Eid S, Simioni P, Moll S.  2014.  THROMBOPHILIC RISK OF INDIVIDUALS WITH COMPOUND FACTOR V LEIDEN AND PROTHROMBIN G20210A GENE MUTATION. AMERICAN JOURNAL OF HEMATOLOGY. 89:E43.

Lim MY, Deal AM, Kim S, Musty MD, Conard J, Simioni P, Dutrillaux F, Eid SS, Middeldorp S, Halbmayer WM et al..  2016.  Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals. EUROPEAN JOURNAL OF HAEMATOLOGY. 97:353-360.

Terriou L, Guitton Z, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lega J-C, Nove-Josserand R, Lioger B et al..  2016.  Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort. BLOOD. 128

Loukidi B, Merzouk H, Merzouk SAhmed, Malti N, Taouli K, Belarbi B, Narce M.  2015.  Thrombosis factors and oxidant/antioxidant markers in obese and hypertensive women during pregnancy. BLOOD PRESSURE. 24:242-249.

Daviet F, Rouby F, Poullin P, Moussi-Frances J, Sallee M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B et al..  2019.  Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 85:403-412.

Grall M, Azoulay E, Galicier L, Provot F, Wynckel A, Poullin P, Grange S, Halimi J-M, Lautrette A, Delmas Y et al..  2017.  Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre. AMERICAN JOURNAL OF HEMATOLOGY. 92:381-387.

Tilley H, Salles G, Molina TJ, Casasnovas R-O, Morschhauser F, Coiffier B.  2018.  Through the Glass Ceiling. JOURNAL OF CLINICAL ONCOLOGY. 36

Haberstroh K, Orth UR, Bouzdine-Chameeva T, Cohen J, Corsi AMaria, Crouch R, De Marchi R.  2018.  Through the lens of self-construal: Cross-cultural variation in consumers' appreciation of harmony in marketing visuals. INTERNATIONAL MARKETING REVIEW. 35:429-457.

Fortwengler D, Marchand D, Thierry J, Pellenard P.  2014.  Thuoux and Saint-Pierre d'Argencon Sections (Subalpine Basin, Southeastern France): Case Studies of Ammonite Biostratigraphy for the Potential Candidate Callovian-Oxfordian GSSP. STRATI 2013. :243-246.

Chalabreysse L, Dubois R, Hofman V, Le Naoures C, Mansuet-Lupo A, de Montpreville VThomas, De Muret A, Parrens M, Piton N, Rouquette I et al..  2021.  Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network. ANNALES DE PATHOLOGIE. 41:154-165.

Abdel-Daim MM, Shaheen HM, Abushouk AIbrahim, Toraih EA, Fawzy MS, Alansari WS, Aleya L, Bungau S.  2018.  Thymoquinone and diallyl sulfide protect against fipronil-induced oxidative injury in rats. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH. 25:23909-23916.

LaFranchi SH.  2021.  Thyroid Function in Preterm/Low Birth Weight Infants: Impact on Diagnosis and Management of Thyroid Dysfunction. FRONTIERS IN ENDOCRINOLOGY. 12:666207.

Rouland A., Buffier P., Petit J-M, Verges B., Bouillet B..  2020.  Thyroiditis: What's new in 2019? REVUE DE MEDECINE INTERNE. 41:390-395.

Silvain J, Cayla G, Beygui F, Range G, Motovska ZJ, Dillinger JGuillaume, Boueri Z, Brunel P, Lhermusier T, Pouillot C et al..  2020.  Ticagrelor versus Clopidogrel in Elective Percutaneous Coronary Intervention : The Alpheus Trial. CIRCULATION. 142:E485-E486.

Silvain J, Lattuca B, Beygui F, Range G, Motovska Z, Dillinger J-G, Boueri Z, Brunel P, Lhermusier T, Pouillot C et al..  2020.  Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial. LANCET. 396:1737-1744.

Allaert F-A, Mazen N-J, Legrand L, Quantin C.  2017.  The tidal waves of connected health devices with healthcare applications: consequences on privacy and care management in European healthcare systems. BMC MEDICAL INFORMATICS AND DECISION MAKING. 17:10.

Semczuk M, Lokas EL, Salomon J-B, Athanassoula E., D'Onghia E.  2018.  Tidally Induced Morphology of M33 in Hydrodynamical Simulations of Its Recent Interaction with M31. ASTROPHYSICAL JOURNAL. 864:34.

Quere R, Saint-Paul L, Carmignac V, Martin RZ, Chretien M-L, Largeot A, Hammann A, de Barros J-PPais, Bastie J-N, Delva L.  2014.  Tif1 gamma regulates the TGF-beta 1 receptor and promotes physiological aging of hematopoietic stem cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 111:10592-10597.